🚀 VC round data is live in beta, check it out!

Hapvida Valuation Multiples

Discover revenue and EBITDA valuation multiples for Hapvida and similar public comparables like ProAssurance, Anadolu Sigorta, Banvida, Progyny and more.

Hapvida Overview

About Hapvida

Hapvida Participacoes Investimento SA is the medical-hospital and dental care company. The company and its subsidiaries are mainly engaged in the sale of health insurance plans and delivering the majority of medical assistance at its own hospitals, clinics, imaging diagnostics and laboratories; and the sale of dental insurance plans for services provided by an accredited network.


Founded

1979

HQ

Brazil

Employees

74.4K

Financials (LTM)

Revenue: $6B
EBITDA: $585M

EV

$3B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Hapvida Financials

Hapvida reported last 12-month revenue of $6B and EBITDA of $585M.

In the same LTM period, Hapvida generated $1B in gross profit, $585M in EBITDA, and had net loss of ($47M).

Revenue (LTM)


Hapvida P&L

In the most recent fiscal year, Hapvida reported revenue of $6B and EBITDA of $809M.

Hapvida expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Hapvida forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$6BXXX$6BXXXXXXXXX
Gross Profit$1BXXX$744MXXXXXXXXX
Gross Margin22%XXX12%XXXXXXXXX
EBITDA$585MXXX$809MXXXXXXXXX
EBITDA Margin10%XXX13%XXXXXXXXX
EBIT Margin3%XXX6%XXXXXXXXX
Net Profit($47M)XXX($28M)XXXXXXXXX
Net Margin(1%)XXX(0%)XXXXXXXXX
Net Debt——$2BXXXXXXXXX

Financial data powered by Morningstar, Inc.

Hapvida Stock Performance

Hapvida has current market cap of $1B, and enterprise value of $3B.

Market Cap Evolution


Hapvida's stock price is $2.65.

See Hapvida trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$1B-0.0%XXXXXXXXX$-0.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Hapvida Valuation Multiples

Hapvida trades at 0.5x EV/Revenue multiple, and 4.7x EV/EBITDA.

See valuation multiples for Hapvida and 15K+ public comps

EV / Revenue (LTM)


Hapvida Financial Valuation Multiples

As of April 14, 2026, Hapvida has market cap of $1B and EV of $3B.

Equity research analysts estimate Hapvida's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Hapvida has a P/E ratio of (26.6x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$1BXXX$1BXXXXXXXXX
EV (current)$3BXXX$3BXXXXXXXXX
EV/Revenue0.5xXXX0.4xXXXXXXXXX
EV/EBITDA4.7xXXX3.4xXXXXXXXXX
EV/EBIT13.7xXXX7.3xXXXXXXXXX
EV/Gross Profit2.1xXXX3.7xXXXXXXXXX
P/E(26.6x)XXX(44.4x)XXXXXXXXX
EV/FCF8.4xXXX6.6xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Hapvida Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Hapvida Margins & Growth Rates

Hapvida's revenue in the last 12 month grew by 8%.

Hapvida's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Hapvida's rule of 40 is 10% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Hapvida's rule of X is 13% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Hapvida and other 15K+ public comps

Hapvida Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth8%XXX2%XXXXXXXXX
EBITDA Margin10%XXX13%XXXXXXXXX
EBITDA Growth(3%)XXX(33%)XXXXXXXXX
Rule of 40—XXX10%XXXXXXXXX
Bessemer Rule of X—XXX13%XXXXXXXXX
Revenue per Employee—XXX$0.1MXXXXXXXXX
Opex per Employee—XXX$0.0MXXXXXXXXX
S&M Expenses to Revenue—XXX1%XXXXXXXXX
G&A Expenses to Revenue—XXX(0%)XXXXXXXXX
Opex to Revenue—XXX6%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Hapvida Public Comps

See public comps and valuation multiples for other Health Benefits & Financial Solutions and Insurance Carriers comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
HapvidaXXXXXXXXXXXXXXXXXX
ProAssuranceXXXXXXXXXXXXXXXXXX
Anadolu SigortaXXXXXXXXXXXXXXXXXX
BanvidaXXXXXXXXXXXXXXXXXX
ProgynyXXXXXXXXXXXXXXXXXX
International General InsuranceXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Hapvida M&A Activity

Hapvida acquired XXX companies to date.

Last acquisition by Hapvida was on XXXXXXXX, XXXXX. Hapvida acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Hapvida

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Hapvida Investment Activity

Hapvida invested in XXX companies to date.

Hapvida made its latest investment on XXXXXXXX, XXXXX. Hapvida invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Hapvida

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Hapvida

When was Hapvida founded?Hapvida was founded in 1979.
Where is Hapvida headquartered?Hapvida is headquartered in Brazil.
How many employees does Hapvida have?As of today, Hapvida has over 74K employees.
Who is the CEO of Hapvida?Hapvida's CEO is Jorge Fontoura Pinheiro Koren de Lima.
Is Hapvida publicly listed?Yes, Hapvida is a public company listed on B3.
What is the stock symbol of Hapvida?Hapvida trades under HAPV3 ticker.
When did Hapvida go public?Hapvida went public in 2018.
Who are competitors of Hapvida?Hapvida main competitors are ProAssurance, Anadolu Sigorta, Banvida, Progyny.
What is the current market cap of Hapvida?Hapvida's current market cap is $1B.
What is the current revenue of Hapvida?Hapvida's last 12 months revenue is $6B.
What is the current revenue growth of Hapvida?Hapvida revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Hapvida?Current revenue multiple of Hapvida is 0.5x.
Is Hapvida profitable?Yes, Hapvida is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Hapvida?Hapvida's last 12 months EBITDA is $585M.
What is Hapvida's EBITDA margin?Hapvida's last 12 months EBITDA margin is 10%.
What is the current EV/EBITDA multiple of Hapvida?Current EBITDA multiple of Hapvida is 4.7x.
What is the current FCF of Hapvida?Hapvida's last 12 months FCF is $329M.
What is Hapvida's FCF margin?Hapvida's last 12 months FCF margin is 5%.
What is the current EV/FCF multiple of Hapvida?Current FCF multiple of Hapvida is 8.4x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial